Sept 10 (Reuters) - GTCR has struck a 4.1 billion-euro
($4.80 billion) deal to buy Czech generic drug maker Zentiva
from Advent International, the Financial Times
reported on Wednesday, citing two people familiar with the
matter.
Reuters could not immediately confirm the report.
($1 = 0.8548 euros)